As reported by The Pharma Letter, the Biopharma specialist, Shire has recently added two extra additions to their team – two senior R&D Executives – one from GlaxoSmithKline and the other from Abbott Laboratories.
Former GlaxoSmithKline R&D Executive, Lawson Macartney, was appointed to the role of Senior Vice President of the Emerging Business Unit at Shire. Whilst, Mario Saltarelli, from Abbott Laboratories has been welcomed as the new Senior VP of Clinical Development and Medical Affairs.
Speaking of the new recruits, Jeffrey Jonas, Senior VP of R&D at Shire, stated, “The experience and expertise that Drs Macartney and Saltarelli bring to the Shire team will help us advance our pipeline, more effectively manage the lifecycle of our medicines and provide growth opportunities – all in the spirit of helping patients with life-altering conditions to lead better lives.”
Are you looking for a new role in the pharmaceutical industry? Click here to search our current pharmaceutical jobs online now.